Pieris Pharmaceuticals, INC Form 4 insider transactions
425: Pieris Pharmaceuticals to Merge with Palvella Therapeutics, Creating Rare Disease Focused Company
Pieris Pharmaceuticals and Palvella Therapeutics have announced a definitive merger agreement to form a clinical-stage biopharmaceutical company focused on rare genetic skin diseases.